Brown Advisory Inc Neogenomics Inc Transaction History

Brown Advisory Inc

$74.6 Billion
Q2 2024

A detailed history of Brown Advisory Inc transactions in Neogenomics Inc stock. As of the latest transaction made, Brown Advisory Inc holds 8,771,361 shares of NEO stock, worth $129 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

8,771,361

Previous 9,669,775 9.29%

Holding current value

$129 Million

Previous $152 Million 19.97%

% of portfolio

0.16%

Previous 0.21%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$13.01 - $15.77 $11.7 Million - $14.2 Million	-898,414 Reduced 9.29%	8,771,361 $122 Million
Q1 2024 Apr 24, 2024	BUY	$14.06 - $16.79 $368,034 - $439,495	26,176 Added 0.27%	9,669,775 $152 Million
Q4 2023 Feb 08, 2024	BUY	$11.67 - $20.73 $16.3 Million - $29 Million	1,397,397 Added 16.95%	9,643,599 $156 Million
Q3 2023 Oct 24, 2023	BUY	$12.15 - $17.85 $20.1 Million - $29.5 Million	1,651,717 Added 25.05%	8,246,202 $101 Million
Q2 2023 Jul 31, 2023	BUY	$14.1 - $19.83 $46,262 - $65,062	3,281 Added 0.05%	6,594,485 $106 Million
Q1 2023 May 08, 2023	BUY	$9.09 - $19.45 $1.7 Million - $3.64 Million	187,219 Added 2.92%	6,591,204 $115 Million
Q4 2022 Feb 13, 2023	BUY	$6.45 - $12.07 $1.44 Million - $2.69 Million	223,250 Added 3.61%	6,403,985 $59.2 Million
Q3 2022 Nov 14, 2022	BUY	$7.86 - $12.91 $3.25 Million - $5.33 Million	413,085 Added 7.16%	6,180,735 $53.2 Million
Q2 2022 Nov 14, 2022	BUY	$7.06 - $13.97 $7.23 Million - $14.3 Million	1,023,999 Added 21.59%	5,767,650 $47 Million
Q2 2022 Sep 13, 2022	BUY	$7.06 - $13.97 $19,852 - $39,283	2,812 Added 0.05%	5,569,547 $45.4 Million
Q2 2022 Aug 02, 2022	BUY	$7.06 - $13.97 $7 Million - $13.9 Million	991,678 Added 21.68%	5,566,735 $46.2 Million
Q1 2022 Nov 14, 2022	SELL	$12.15 - $35.28 $10 Million - $29.1 Million	-825,896 Reduced 14.83%	4,743,651 $57.6 Million
Q1 2022 Sep 13, 2022	SELL	$12.15 - $35.28 $7,873 - $22,861	-648 Reduced 0.01%	4,575,057 $55.6 Million
Q1 2022 May 09, 2022	BUY	$12.15 - $35.28 $10.4 Million - $30.3 Million	859,693 Added 23.13%	4,575,705 $56.3 Million
Q4 2021 Jan 27, 2022	BUY	$30.49 - $48.49 $11.2 Million - $17.8 Million	366,464 Added 10.94%	3,716,012 $127 Million
Q3 2021 Nov 12, 2021	BUY	$41.66 - $52.52 $1.63 Million - $2.05 Million	39,079 Added 1.18%	3,349,548 $162 Million
Q2 2021 Jul 29, 2021	BUY	$36.62 - $51.69 $6.14 Million - $8.67 Million	167,759 Added 5.34%	3,310,469 $150 Million
Q1 2021 May 14, 2021	BUY	$41.56 - $59.88 $2.79 Million - $4.02 Million	67,143 Added 2.18%	3,142,710 $152 Million
Q4 2020 Feb 12, 2021	SELL	$36.08 - $56.47 $25.1 Million - $39.4 Million	-696,981 Reduced 18.48%	3,075,567 $166 Million
Q3 2020 Nov 16, 2020	BUY	$33.26 - $40.48 $2.13 Million - $2.59 Million	64,095 Added 1.73%	3,772,548 $139 Million
Q2 2020 Aug 14, 2020	BUY	$24.21 - $31.02 $24.4 Million - $31.3 Million	1,008,025 Added 37.33%	3,708,453 $115 Million
Q1 2020 May 15, 2020	BUY	$20.5 - $34.53 $466,662 - $786,040	22,764 Added 0.85%	2,700,428 $74.6 Million
Q4 2019 Feb 14, 2020	BUY	$18.96 - $29.84 $1.3 Million - $2.05 Million	68,649 Added 2.63%	2,677,664 $78.3 Million
Q3 2019 Nov 14, 2019	BUY	$19.12 - $26.24 $1.59 Million - $2.18 Million	83,172 Added 3.29%	2,609,015 $49.9 Million
Q2 2019 Aug 12, 2019	BUY	$19.57 - $24.1 $166,814 - $205,428	8,524 Added 0.34%	2,525,843 $55.4 Million
Q1 2019 May 15, 2019	BUY	$12.14 - $20.46 $920,831 - $1.55 Million	75,851 Added 3.11%	2,517,319 $51.5 Million
Q4 2018 Feb 13, 2019	BUY	$11.24 - $18.5 $10.9 Million - $18 Million	972,288 Added 66.18%	2,441,468 $30.8 Million
Q3 2018 Nov 13, 2018	BUY	$12.5 - $15.38 $18.4 Million - $22.6 Million	1,469,180 New	1,469,180 $22.6 Million

Others Institutions Holding NEO

# of Institutions

278

Shares Held

127M

Call Options Held

581K

Put Options Held

107K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.86B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

News

Stay updated on Brown Advisory Inc with notifications on news.

Account

Brown Advisory Inc Neogenomics Inc Transaction History